PropertyValue
?:abstract
  • Patients diagnosed with COVID-19 who require critical care often have comorbidities, such as chronic obstructive pulmonary disease, asthma, diabetes, hypertension, and obesity 3 In the more severe cases, patients require ventilatory support in the intensive care unit due to severe respiratory failure, and multiple organ dysfunction syndromes 3 As of September 9, 2020, there have been 27,605,560 confirmed cases of COVID-19 worldwide, and 6,328,099 in the United States Lack of time to adequately perform randomized control trials to determine the most efficient treatment plan is a major rate-limiting factor in determining optimal management of the disease With more data in real-time, the REMAP uses an algorithm to assess which therapies are providing the most beneficial outcomes, and those therapies are assigned more frequently to COVID-19 positive patients 7 This results in more patients receiving the most beneficial treatment and therapy without the length of time it would require to complete traditional randomized controlled trials
is ?:annotates of
?:creator
?:journal
  • The_International_Student_Journal_of_Nurse_Anesthesia
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • Artificial Intelligence to Determine Treatment of COVID-19
?:type
?:who_covidence_id
  • #891813
?:year
  • 2020

Metadata

Anon_0  
expand all